COMMUNIQUÉS West-GlobeNewswire

SK pharmteco annonce une collaboration stratégique avec Orphan Therapeutics Accelerator pour le développement et la fabrication de produits thérapeutiques visant les maladies rares
18/06/2026
RANCHO CORDOVA, Californie, 18 juin 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour un accord de collaboration avec Orphan Therapeutics Accelerator (OTXL), une organisation à but non lucratif spécialisée dans les [...]
FamilyWell Health Launches Menopause Hub, Setting the Standard for Behavioral Health in Midlife Care
18/06/2026
Program introduces free clinical guidelines for women’s health providers and a comprehensive behavioral health certification for coaches and clinicians BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- FamilyWell Health , the [...]
Legend Senior Living Co-CEO Matt Buchanan Named to Senior Housing News' 2026 Executives to Watch List
18/06/2026
WICHITA, Kan., June 18, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living is proud to announce that President and Co-CEO Matt Buchanan has been recognized as one of Senior Housing News' 2026 Executives to Watch , an annual [...]
SK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapies
18/06/2026
RANCHO CORDOVA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a collaborative agreement with the Orphan Therapeutics Accelerator (OTXL), a non-profit, biotech focused on completing development [...]
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
18/06/2026
Study results expected to support design and initiation of a pivotal Phase 3 clinical trial in the treatment of metastatic pancreatic cancer OCALA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE [...]
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
18/06/2026
President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present Company's vision for transforming women's health SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. ( [...]
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
18/06/2026
MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
18/06/2026
VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc., a Vancouver-based biopharmaceutical company focused on skin health and longevity, today announced positive preclinical [...]
BiomX Provides Update on Defense Technology Portfolio and Growth Strategy
18/06/2026
Presentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threats NETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE [...]
New Research from Marius Pharmaceuticals Reveals Major Men's Health Awareness Gap: 65% Have Never Had Their Testosterone Levels Tested
18/06/2026
National survey finds many men are experiencing symptoms, delaying medical care, and reporting health concerns that impact work, relationships, and daily life RALEIGH, N.C., June 18, 2026 (GLOBE NEWSWIRE) -- New [...]
NMDP Teams Up with Boozer Brothers to Help More Patients Access Blood Stem Cell Transplants
18/06/2026
The brothers urge young adults to join the NMDP Registry and help save lives by supporting patient access to blood stem cell transplants MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- NMDP, a global nonprofit leader in [...]
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
18/06/2026
Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases Denali was awarded Priority Review Voucher [...]
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
18/06/2026
Principal Investigator Kathleen N. Moore, M.D., a leading expert in advanced ovarian cancer, will present the poster TARPON SPRINGS, Fla., June 18, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) ( [...]
Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026
18/06/2026
MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced [...]
Essential Pharma appoints Becki Morison as Chief Executive Officer
18/06/2026
Pharmaceutical executive brings 25+ years of international commercial leadership and rare disease experience Egham, UK – 18 June 2026 – Essential Pharma ("Essential" or "the Company"), a global pharmaceutical company [...]
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
18/06/2026
SUNNYVALE, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today [...]
Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
18/06/2026
SARASOTA, FLA., June 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
18/06/2026
-- First clinical authorization for an in vivo Prime Editing therapy from Prime Medicine -- -- PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing allele in North America and Europe [...]
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
18/06/2026
Broader pharmacy access, channel expansion, and payer coverage position Arbli ™ for increased prescription volume and revenue growth COMMACK, NY, June 18, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX [...]

Pages